231 related articles for article (PubMed ID: 35778411)
1. Metabolic modeling-based drug repurposing in Glioblastoma.
Tomi-Andrino C; Pandele A; Winzer K; King J; Rahman R; Kim DH
Sci Rep; 2022 Jul; 12(1):11189. PubMed ID: 35778411
[TBL] [Abstract][Full Text] [Related]
2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
3. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing: a promising tool to accelerate the drug discovery process.
Parvathaneni V; Kulkarni NS; Muth A; Gupta V
Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
[TBL] [Abstract][Full Text] [Related]
5. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract][Full Text] [Related]
6. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
8. Towards the routine use of in silico screenings for drug discovery using metabolic modelling.
Bintener T; Pacheco MP; Sauter T
Biochem Soc Trans; 2020 Jun; 48(3):955-969. PubMed ID: 32369553
[TBL] [Abstract][Full Text] [Related]
9. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
10. Considerations and challenges for sex-aware drug repurposing.
Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
[TBL] [Abstract][Full Text] [Related]
11. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
[TBL] [Abstract][Full Text] [Related]
12. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
Elife; 2017 Sep; 6():. PubMed ID: 28936969
[TBL] [Abstract][Full Text] [Related]
13. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing for the treatment of glioblastoma multiforme.
Abbruzzese C; Matteoni S; Signore M; Cardone L; Nath K; Glickson JD; Paggi MG
J Exp Clin Cancer Res; 2017 Nov; 36(1):169. PubMed ID: 29179732
[TBL] [Abstract][Full Text] [Related]
15. [Data-driven drug discovery for drug repurposing].
Saito R; Yano N; Kojima S; Miyoshi F
Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
[TBL] [Abstract][Full Text] [Related]
16. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
17. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning.
Turanli B; Zhang C; Kim W; Benfeitas R; Uhlen M; Arga KY; Mardinoglu A
EBioMedicine; 2019 Apr; 42():386-396. PubMed ID: 30905848
[TBL] [Abstract][Full Text] [Related]
18. Current state and future perspective of drug repurposing in malignant glioma.
Siegelin MD; Schneider E; Westhoff MA; Wirtz CR; Karpel-Massler G
Semin Cancer Biol; 2021 Jan; 68():92-104. PubMed ID: 31734137
[TBL] [Abstract][Full Text] [Related]
19. Computational Methods for Drug Repurposing.
Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
[TBL] [Abstract][Full Text] [Related]
20. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
